Asha Nayak

The Search for Cures Leads to Silicon Valley

Lindy Fishburne, Linda Avey, Noah Craft, Lloyd Minor, Asha Nayak, Lisa Suennen, Asha Rogers, Martha Minow, Male Speaker 2, Brody

Hosted by Lindy Fishburne, a panel of leaders from Intel, Stanford Medicine, 23andMe, and Science 37 discussed the strategic shift from reactive sick care to proactive precision health through decentralized data models and consumer engagement. Initiatives such as Intel's Collaborative Cancer Cloud, Stanford's genomic-phenotypic integration, and Science 37's patient-centric trials aim to dismantle data silos while accelerating drug discovery and increasing trial diversity. The dialogue further emphasized that sustainable innovation requires overcoming reimbursement barriers and establishing patient data sovereignty to enable real-world evidence generation.